Detachable String Magnetically Controlled Capsule Endoscopy for Detecting High-risk Varices in Compensated Cirrhosis
NCT03749954 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 105
Last updated 2020-11-17
Summary
Gastroesophageal varices is a serious complication of compensated advanced chronic liver disease (cACLD). Primary prophylaxis to reduce the risk of variceal haemorrhage is recommended if high-risk varices (HRV) are detected. We performed this study to compare the accuracy, patients' satisfaction and safety of detection of HRV by detachable string magnetically controlled capsule endoscopy (DS-MCCE) with esophagogastroduodenoscopy (EGD) as the standard.
Conditions
- Compensated Cirrhosis
- Gastroesophageal Varices Bleeding
Interventions
- DIAGNOSTIC_TEST
-
Detachable string magnetically controlled capsule endoscopy
Esophagogastroduodenoscopy is performed 2 hours after the magnetically controlled capsule endoscopy (Ankon Medical Technologies Co. Ltd.).
Sponsors & Collaborators
-
Beijing 302 Hospital
collaborator OTHER -
Sir Run Run Shaw Hospital
collaborator OTHER -
Zhujiang Hospital
collaborator OTHER -
Shandong Provincial Hospital
collaborator OTHER_GOV -
Shanghai Tongji Hospital, Tongji University School of Medicine
collaborator OTHER -
Third Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Guangdong Second Provincial General Hospital
collaborator OTHER -
The Fifth Affiliated Hospital of Zunyi Medical College
collaborator OTHER -
LanZhou University
collaborator OTHER -
Sheffield Teaching Hospitals NHS Foundation Trust
collaborator OTHER -
Changhai Hospital
collaborator OTHER -
The Second Affiliated Hospital of Baotou Medical College
collaborator OTHER -
Nanfang Hospital, Southern Medical University
lead OTHER
Principal Investigators
-
Xiaolong Qi, M.D. · LanZhou University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-09
- Primary Completion
- 2019-12-03
- Completion
- 2022-11-08
Countries
- China
- United Kingdom
Study Locations
More Related Trials
-
Development and Validation of an Noninvasive Model for Predicting High Risk Esophageal Varices in Cirrhosis
NCT04210297 ·Status: COMPLETED
-
Feasibility and Safety Evaluation of Endoscopic Treatment of Esophagogastric Varices in Cirrhosis on the Day-care Unit
NCT07129447 ·Status: NOT_YET_RECRUITING
-
Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)
NCT04546360 ·Status: COMPLETED
-
Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
NCT05485714 ·Status: COMPLETED
-
Algorithm to Stratify Clinical Decompensation Risk in Patients With Compensated Advanced Chronic Liver Disease (CHESS2108)
NCT05100485 ·Status: COMPLETED
-
Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma
NCT05017922 ·Status: COMPLETED ·Phase: NA
-
A Prospective Evaluation of Computerized Tomographic(CT) Scanning as a Screening Modality for Esophageal Varices
NCT00587197 ·Status: COMPLETED
-
A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in Cirrhosis
NCT05979935 ·Status: ACTIVE_NOT_RECRUITING
-
The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis
NCT07151885 ·Status: RECRUITING ·Phase: NA
-
Non-invasive Methods for Predicting Decompensation of Chronic Liver Disease
NCT06741904 ·Status: ENROLLING_BY_INVITATION
-
Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients
NCT05629845 ·Status: RECRUITING ·Phase: NA
-
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
NCT05475015 ·Status: RECRUITING
-
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
NCT04883177 ·Status: COMPLETED
-
Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension
NCT04994548 ·Status: COMPLETED
-
Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
NCT04640350 ·Status: UNKNOWN
-
Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology
NCT05551884 ·Status: UNKNOWN
-
GastrOesophageal Varices After Sustained Virological Response
NCT04191018 ·Status: UNKNOWN
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
A Novel Imaging Based Quantitative Model-aided Detection of Portal Hypertension in Patients With Cirrhosis (CHESS2104)
NCT05068492 ·Status: NOT_YET_RECRUITING
-
Position Changes in Cirrhosis Hemorrhagic Spot Detection
NCT05165043 ·Status: UNKNOWN
-
A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis (CHESS2202)
NCT05251272 ·Status: UNKNOWN
-
Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance
NCT02854241 ·Status: UNKNOWN ·Phase: NA
-
Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension
NCT03277651 ·Status: UNKNOWN
-
Multimodal Ultrasound and Portal Hypertension
NCT05789641 ·Status: UNKNOWN
-
An AI Model Based on Smartphone-derived Multimodality Images to Evaluate Portal Hypertension in Patients With Cirrhosis (CHESS2203)
NCT05402410 ·Status: UNKNOWN